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Abstract
Background: Gestational diabetes is a prevalent disease associated with adverse outcomes of
pregnancy. Smoking as been associated with glucose intolerance during pregnancy in some but not
all studies. Therefore, we aimed to systematically review all epidemiological evidence to examine
the association between cigarette smoking during pregnancy and risk of developing gestational
diabetes mellitus.
Methods: We conducted a systematic review of articles published up to 2007, using PubMed,
Embase, LILACS e CINAHL to identify the articles. Because this review focuses on studies of
smoking during pregnancy, we excluded studies evaluating smoking outside pregnancy. Two
investigators independently abstracted information on participant's characteristics, assessment of
exposure and outcome, and estimates for the association under study. We evaluated the studies
for publication bias and performed heterogeneity analyses. We also assessed the effect of each
study individually through sensitivity analysis.
Results: We found and critically reviewed 32 studies, of which 12 met the criteria for inclusion in
the review. Most of the studies provided only unadjusted measurements. Combining the results of
the individual studies, we obtained a crude odds ratio of 1.03 (99% CI 0.85–1.25). Only 4 studies
presented adjusted measurements of association, and no association was found when these alone
were analyzed (OR 0.95; 99% CI 0.85–1.07). Subgroup analysis could not be done due to small
sample size.
Conclusion: The number of studies is small, with major heterogeneity in research design and
findings. Taken together, current data do not support an association between cigarette smoking
during pregnancy and the risk of gestational diabetes.
Background
Gestational diabetes mellitus (GDM) is defined as glucose
intolerance with onset or first recognition during preg-
nancy [1], and affects 1 to 15% of all pregnancies overall
[2] and 7.6% of pregnancies in Brazil [3]. The prevalence
of gestational diabetes mellitus varies in direct proportion
Published: 16 December 2008
BMC Pregnancy and Childbirth 2008, 8:53 doi:10.1186/1471-2393-8-53
Received: 26 March 2008
Accepted: 16 December 2008
This article is available from: http://www.biomedcentral.com/1471-2393/8/53
© 2008 Wendland et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Pregnancy and Childbirth 2008, 8:53 http://www.biomedcentral.com/1471-2393/8/53
Page 2 of 8
(page number not for citation purposes)
with the prevalence of type 2 diabetes and is increasing
over time along with the prevalence of obesity [4]. Its
onset is associated with increased rates of macrosomia
which in turn increases the risk of cesarean section, shoul-
der dystocia and birth trauma [3,5,6]. A long-term conse-
quence of gestational diabetes for the mother is increased
risk of progression to type 2 diabetes later in life [7,8].
Many predisposing factors, such as advanced age, obesity,
non-Caucasian ethnicity, and family history of type 2 dia-
betes have been associated with an increased risk of gesta-
tional diabetes [9,10]. Previous gestational diabetes,
unexplained fetal loss or newborns large for gestational
age have also been linked to an increased risk of gesta-
tional diabetes mellitus [11].
Although a tendency of reduction in the number of
women who smoke during pregnancy has been observed
[12], cigarette smoking is still common during pregnancy
[13-16]. Smoking during pregnancy has been associated
with short and long term adverse outcomes including pre-
mature rupture of fetal membranes, placenta previa, pla-
cental abruption [17], preterm delivery [18], and future
childhood obesity and hypertension [19]. Increased insu-
lin resistance [20,21], hyperinsulinemia and type 2 diabe-
tes have been linked with cigarette smoking outside of
pregnancy in some but not all studies [18,22], but
whether cigarette smoking is a risk factor for the develop-
ment of gestational diabetes remains controversial
[23,24]. Intriguingly, smoking has been negatively associ-
ated with pre-eclampsia [25] and, more recently, outside
of pregnancy, with reduced risk of some gastrointestinal
diseases [26] and Parkinson's disease [27].
Given this uncertainty about the relationship between
smoking in pregnancy and GDM, the aim of this study is
to systematically review all epidemiological evidence on
the relation between smoking habits during pregnancy
and risk of gestational diabetes mellitus.
Methods
A specific protocol was designed for this systematic
review, which was reported in accordance with the check-
list proposed by the Meta-analysis of Observational Stud-
ies in Epidemiology (MOOSE) group [28].
Search strategies
We searched for published and unpublished studies
reported from 1970 to 2006 in PubMed http://
www.ncbi.nlm.nih.gov. The electronic search strategy was
constructed using the key terms suggested by the Meta-
bolic and Endocrine Disorders Group [29], Pregnancy and
Childbirth Group [30] and Tobacco Addiction Group
[31]: "smoke" or "smoking" or "tobacco use" or "ciga-
rette" combined with "gestational diabetes" or ("diabe-
tes" and "pregnancy") in text words or medical subject
headings. We used similar strategies to search LILACS
(Latin America and Caribbean database), EMBASE and
CINAHL. Additionally, to avoid publication bias, we did
a broader search, generically using the term "risk factor",
looking for articles in which smoking was not necessarily
the primary exposure. We manually searched reference
lists of retrieved articles and of relevant reviews, as well as
web pages of selected ministries of health and other
potentially relevant internet sources. No attempt was
made to contact the authors of any of these studies in
order to get primary data. We restricted our search to stud-
ies of humans, with no language restrictions.
Criteria for considering studies
We considered all observational studies that assessed the
association between smoking cigarettes during pregnancy
and gestational diabetes, and which provided adjusted or
crude relative risks (RR), odds ratios (OR) or information
that enabled us to calculate the crude measures of associ-
ation. The diagnosis of gestational diabetes had to be
obtained by an oral glucose tolerance test (OGTT) or by a
clinical diagnosis. We excluded studies of type 1 diabetes,
reports of tobacco products other than cigarettes, animal
studies and case series. Studies not having a clear state-
ment that smoking occurred during pregnancy, not hav-
ing exposure measured before the outcome, or not having
a clear definition of the diagnostic process for the out-
come were not included.
Study selection and data extraction
Titles and abstracts of the resulting publications were
screened for articles of possible interest by two independ-
ent investigators (E.M.W. – obstetrician and M.E.P. – pri-
mary care physician). When the information provided by
the title and abstract was not sufficient to determine exclu-
sion, we evaluated the full-text. For data extraction, we
adapted a form recommended by Cochrane Non-Rand-
omized Studies Methods Group [32]. Two investigators
independently abstracted information on participant
characteristics, measurements of smoking habits and out-
comes, adjustment for potential confounders, and esti-
mates of association. Discrepancies were resolved by
discussion and repeated examination of the articles and,
when necessary, through consultation of a third author
(M.I.S.).
Appraisal of methodological quality of primary studies
All articles meeting the eligibility criteria were assessed for
their methodological quality by two independent investi-
gators (E.M.W. and M.E.P). This assessment involved scru-
tinizing study design, sampling method, source of data
and definition of exposure and diagnostic procedures. The
presence of clear definitions of exposure and diagnostic
methods were regarded as an indication of higher quality.BMC Pregnancy and Childbirth 2008, 8:53 http://www.biomedcentral.com/1471-2393/8/53
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Data synthesis and statistical analysis
We used MIX – Meta-analysis with Interactive Explana-
tions (version 1.54) [33] for all statistical analyses. When
an unadjusted odds ratio (OR) for smoking – gestational
diabetes mellitus association was not provided in the
manuscript, we manually calculated it from the data pro-
vided. Data input was double-checked for accuracy, and
the ORs calculated by MIX were compared to the ORs
reported in the original studies.
Combination of results involved inverse-variance-
weighted averages of the log odds ratio [ln(OR)]. Initially,
the overall association was calculated using a Mantel-
Haenzel fixed-effects model. Heterogeneity was assessed
using Cochran's Q test. As this test is considered to have
low statistical power, especially when the number of stud-
ies included in the meta-analysis is small (< 20), a random
effect model (DerSimonian-Laird) was used if the P-value
was less than 0.1 [34]. Confidence intervals of 99% were
used for individual and overall associations to allow for
the increased possibility of random error in multiple com-
parisons. Meta-analysis was applied to crude odds ratios,
and, when available, additionally to adjusted odds ratios.
Degree of adjustment for potential confounders were cat-
egorized as "+" for age; "++" for age plus BMI; "+++" for
these plus weight gain during pregnancy.
Publication bias was evaluated quantitatively using
Egger's regression, in which the standardized effect esti-
mates are regressed against estimated precision [35]. We
did not employ graphical methods such as the funnel plot
as this technique requires a larger number of studies to
provide an adequate graph [36]. To investigate the impact
of the control for confounding factors on the study esti-
mates, we grouped the studies according with the pres-
ence or absence of adjustments.
In addition, to evaluate the stability of the results of this
meta-analysis and to explore the effect of heterogeneity in
studies, we also performed a one-way sensitivity analysis.
By removing one study at a time and recalculating the
odds ratio, we observed the effect of each study on the
summary estimate, thus evaluating the robustness of the
results [35]. When possible, additional meta-analyses
were performed on relevant sub-groups of studies to
investigate possible causes of heterogeneity.
Results
We initially identified 1439 references, 1354 in Medline,
68 in EMBASE, 9 in LILACS and 8 in CINAHL. After exclu-
sions determined by abstract review, 32 studies were con-
sidered. Of these, we excluded an additional 20 studies,
12 thus remaining for the systematic review (Figure 1).
These exclusions were due to not assessing smoking dur-
ing pregnancy [37]; not having a clear definition of the
diagnostic process [38-43] or diagnosing GDM with intra-
venous tolerance testing [44,45]; lacking sufficient infor-
mation to calculate measures of association [46-48]; not
providing primary data [49]; not ascertaining GDM [50-
55]; or not assessing the exposure before the outcome
[56].
Table 1 shows selected characteristics of the studies ana-
lyzed. Two studies that investigated the same study popu-
lation [24,57], but with somewhat different sample size
and results, were included. All studies that provided
adjusted measurements included age in the analysis.
As shown in Additonal File 1, universal and selective
screening (or both) for gestational diabetes was used.
Four studies used the 2-h OGTT (WHO definition), seven
used the 3-h OGTT (ADA definition), one used more than
one criteria for diagnosis of GDM and another used the
ICD-code for gestational diabetes. Studies varied in their
classification of smoking status. For example, some sepa-
rated women who quit smoking before and during preg-
nancy. Others pooled all women who smoked any
cigarette during pregnancy. Only three studies provided
measurements of association for different smoking cate-
gories [23,24,58]. All studies were based on self-report of
smoking. None of the studies evaluated in this systematic
review provided information about the type of cigarettes
smoked.
As significant heterogeneity between studies was found in
the meta-analysis of the nine [24,57,59-65] reports of
crude associations (Q = 50.14; p < 0.01), we used a ran-
dom effects method for this analysis (Figure 2). No asso-
ciation between smoking during pregnancy and GDM was
present in such analysis, the summary unadjusted OR
being 1.03 (99% CI 0.85–1.25).
Only four studies, including five distinct populations,
described adjusted odds ratios and assessed potential con-
founders when non smokers were compared to current
smokers [24,59,66,67]. As heterogeneity between studies
did not reach statistical significance in the adjusted meta-
analysis (Q = 7.0; p = 0.14), we used a fixed effects model.
Combining the adjusted results produced an overall odds
ratio of 0.95 (99% CI 0.85–1.07; p = 0.27) (Figure 3).
Since the native Cree Canadian population has a high
prevalence of gestational diabetes [68], we conducted a
sensitivity analysis excluding this population; only mini-
mal changes were found in the summary measurement
(OR = 0.97; 95% CI 0.69–1.38). Sub-group analysis by
type of diagnostic criteria (3-hour OGTT versus 2-h
OGTT), did not reveal important differences. Additional
sub-group analysis by gestational age of smoking assess-
ment showed that when smoking was assessed at less than
24 weeks of pregnancy [24,57,62,63,65], the combinedBMC Pregnancy and Childbirth 2008, 8:53 http://www.biomedcentral.com/1471-2393/8/53
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crude OR, using a random effects model, was 1.22 (99%
CI 0.73–2.04), whereas when smoking was assessed at
later than 24 weeks [59,61,64,69], it was 0.88 (99% CI
0.70–1.10).
We identified three studies, assessing different levels of
smoking [23,24,70] (Additonal File 1). A fixed effects
analysis showed no association of light smoking (1–9 cig/
day) with GDM (OR = 0.94; 99% CI 0.83–1.06), without
heterogeneity between studies (Q = 4.25; p = 0.24). Only
two studies [23,58] presented comparable categories for
heavy smokers (more than 10 cig/day). In a random
effects model, given that significant heterogeneity was
present (Q = 5.66; p = 0.06), similar results were found for
women that smoked 10 or more than cigarettes per day
during pregnancy (OR = 0.72; 99% CI 0.37–1.42).
The Egger's test provided no evidence of publication bias
for the unadjusted (p = 0.31) or adjusted (p = 0.92) over-
all associations of smoking with gestational diabetes. In
the sensitivity analysis, the overall heterogeneity and asso-
ciation size were recalculated by iteratively removing one
study at a time. This analysis confirmed the stability of the
summary risk estimate (Additonal File 2).
Discussion
Cigarette smoking has been considered as a risk factor for
diabetes outside of pregnancy [20,71] and as such, could
also be seen as a risk factor for gestational diabetes
[24,37]. However, our meta-analysis does not support the
Flow diagram of the study selection process summarizing study assessment and exclusion stages Figure 1
Flow diagram of the study selection process summarizing study assessment and exclusion stages.
  
1362 articles judged 
not to be relevant 
20 articles excluded on the basis of: 
1- Not providing primary data 
1- Type 1 diabetes being the outcome 
5- Gestational diabetes not being the outcome 
2- Intravenous glucose tolerance test for the diagnosis 
of outcome 
6- Incomplete information on exposure assessment 
3- Not enough data  
1- Smoking being assessed outside of pregnancy 
1- Exposure being measured after the outcome  
1439 citations identified 
1394 titles and abstracts 
of potentially relevant 
articles. 
45 duplicates 
32 articles examined 
in detail 
12 articles included 
Table 1: One-way sensitivity analysis.
Study excluded Random effects model
Odds ratio 99% CI
Wendland et al[59] 1.03 0.72–1.48
England et al. [24] 0.94 0.84–1.06
Xiong et al. [60] 0.95 0.85–1.07
Rodrigues et al. Cree [66] 0.96 0.85–1.07
Rodrigues et al. Non-native [66] 0.95 0.85–1.07BMC Pregnancy and Childbirth 2008, 8:53 http://www.biomedcentral.com/1471-2393/8/53
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Meta-analysis of unadjusted results of studies of the association between smoking and gestational diabetes Figure 2
Meta-analysis of unadjusted results of studies of the association between smoking and gestational diabetes. 
Black squares indicate the odds ratio in each study and the horizontal lines represent 99% confidence intervals. Random-effects 
model.
Weight (%) Association measure
0,1 1 10
OR (log scale)
S
t
u
d
i
e
s
Study Year (99% CI)
Wendland et al. (58) 2007 12.00% 0.87 (0.59  to  1.27)
England et al. (24) 2004 7.00% 2.43 (1.22  to  4.86)
Xiong et al. (59) 2001 16.00% 0.81 (0.72  to  0.91)
Berkowitz et al.(60) 1992 9.00% 0.82 (0.48  to  1.41)
Ostlund et al. (61) 2004 16.00% 1.01 (0.9  to  1.13)
Wolf et al. (62) 2003 11.00% 0.85 (0.54  to  1.34)
Bo et al. (63) 2001 9.00% 1.36 (0.75  to  2.46)
Joffe et al. (57) 1998 7.00% 2.72 (1.37  to  5.41)
Cosson et al. (64) 2005 12.00% 0.65 (0.43  to  0.99)
META-ANALYSIS 100% 1.03 (0.8 to 1.32)
0.1
OR
Meta-analysis of adjusted results of studies of the association between smoking during pregnancy and gestational diabetes Figure 3
Meta-analysis of adjusted results of studies of the association between smoking during pregnancy and gesta-
tional diabetes. Black squares indicate the odds ratio in each study, with the square size proportional to the weight of the 
study in the meta-analysis and the horizontal lines represent 99% confidence intervals. Fixed-effects model.
0,1 1 10
OR (log scale)
S
t
u
d
i
e
s
Degree of  Weight (%) Association measure
Study Year adjustment (99% CI)
Wendland et al. (58) 2007 +++ 7.21% 0.74 (0.48  to  1.14)
England et al. (24) 2004 ++ 1.88% 1.90 (0.82  to  4.41)
Xiong et al. (59) 2001 + 87.23% 0.96 (0.85  to  1.09)
Rodrigues et al. Cree (65) 1999 + 1.62% 0.77 (0.31  to  1.91)
Rodrigues et al. Non-native (65) 1999 + 2.06% 0.96 (0.43  to  2.14)
META-ANALYSIS 100% 0.95 (0.85 to 1.07)
0.1
ORBMC Pregnancy and Childbirth 2008, 8:53 http://www.biomedcentral.com/1471-2393/8/53
Page 6 of 8
(page number not for citation purposes)
hypothesis that smoking during pregnancy increases the
risk of gestational diabetes.
To our knowledge, this is the first systematic review and
meta-analysis evaluating the association of smoking dur-
ing pregnancy and gestational diabetes. Although we
found a great diversity in the assessment of outcomes and
adjustment for confounding variables, sensitivity analysis
did not reveal an important influence of any single study
(Additonal File 2). As our results are based on published
studies only, other small studies describing a null associa-
tion may have escaped identification.
The evidence published so far for the association between
smoking and gestational diabetes is inconsistent
[23,24,60,66]. How to reconcile these differences is not
clear. It is possible that differences between the study set-
tings such as screening procedures for GDM, or due to var-
iations in the content of cigarettes [72] or in the frequency
of stopping smoking during pregnancy may explain this
inconsistency. Lumping ex-smokers with never smokers
could raise the risk in this comparison group, producing
an apparent lower risk in smokers. However the only two
studies explicitly reporting data on quitters in the adjusted
models showed inconsistent results [59,73].
One such difference meriting special consideration is the
moment of measuring smoking during pregnancy. Smok-
ing cessation or reduction in the number of cigarettes
smoked during pregnancy accentuates gestational weight
gain [74], an important risk factor for gestational diabetes
[75]. Thus, failure to identify smokers who quit after
ascertainment or who reduced the number of cigarettes
smoked during pregnancy may lead to information bias,
erroneously attributing the association found to smoking
rather than to its reduction. Furthermore, social pressure
to quit smoking may lead to erratic smoking behavior dur-
ing pregnancy, difficult to access in epidemiologic studies
[76]. In this regard, our meta-analysis of reports that
assessed smoking earlier in pregnancy [24,57,62,63,65]
showed a tendency to present an increased risk of devel-
oping gestational diabetes, while our meta-analysis of
studies that ascertained smoking later in pregnancy, and
thus possibility more accurately, [59-61,66] showed odds
ratios slightly less than 1.
Our study illustrates the difficulties of systematic reviews
of observational studies. We identified a variety of defini-
tions in the ascertainment of gestational diabetes and part
of the variation in the results between studies may be
related to this variation. Moreover, the degree of informa-
tion in the reports is frequently less than desirable.
Aspects such as characteristics of the population, defini-
tions of exposures and of diagnostic procedures and thus
outcomes, statistical analysis routines and measures of
association are not systematically described in the reports,
limiting the comparability of the studies and utility of
some of the extracted data. The inclusion of two studies
[24,57] referring to the same population in the crude
analysis may have biased the crude estimate slightly
upward. However, this does not appear to have been an
important problem as the adjusted analysis, in which only
one of these studies was included, showed a similar result.
Other limitations of the present meta-analysis must be
considered. The small number of reports published did
not allow us to do extensive sensitivity nor subgroup anal-
yses. Another potential limitation, as previously men-
tioned, is information bias with respect to categorization
of cigarette smoking, as all studies were based on a limited
assessment by self-reports of smoking habits. As women
in general tend to under-report smoking during preg-
nancy by about 15% [77], non-differential misclassifica-
tion could bias the results to the null.
Conclusion
Current data demonstrate important heterogeneity and,
when taken together, do not support an association
between cigarette smoking during pregnancy and the risk
of gestational diabetes. Further research with more
detailed and objective measurements of smoking is
needed to evaluate this association. In vitro and animal
studies may further help to clarify possible biologic mech-
anisms and pathways by which cigarette smoking may
play a role in the development of gestational diabetes.
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